Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$111.85
0.490.44%
Last update: Aug 25, 7:26 AM
Monopar Therapeutics Inc (MNPR) Stock Price, Quote, News & History
MNPRNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Monopar Therapeutics (MNPR) stock?
You can purchase shares of Monopar Therapeutics (NASDAQ:MNPR) through any online brokerage.
Who are Monopar Therapeutics (MNPR) competitors?
Other companies in Monopar Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Monopar Therapeutics (MNPR) stock?
Monopar Therapeutics has a consensus price target of $95.87.
What is the current price for Monopar Therapeutics (MNPR)?
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $111.85 last updated August 25, 2026 at 7:26 AM EDT.
Does Monopar Therapeutics (MNPR) pay a dividend?
There are no upcoming dividends for Monopar Therapeutics.
When is Monopar Therapeutics (NASDAQ:MNPR) reporting earnings?
Monopar Therapeutics does not have any upcoming earnings scheduled.
Is Monopar Therapeutics (MNPR) going to split?
There is no upcoming split for Monopar Therapeutics.
What sector and industry does Monopar Therapeutics (MNPR) operate in?
Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
